Want to join the conversation?
In the Surgical Heart Valve Therapy product group, 1Q16 sales were up slightly over 1Q15 on an underlying basis. In the Critical Care product group, sales grew 9% on an underlying basis, driven by enhanced surgical recovery program, which recorded double-digit underlying sales growth across most regions.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?